NEUROKINE PHARMACEUTICALS INC. - Balance Sheets (USD $)	Jan. 31, 2013		Jan. 31, 2012
Current Assets:
Cash	$ 475		$ 2,061
Amounts receivable	4,254
TOTAL CURRENT ASSETS	4,729		2,061
Property and equipment	1,328	[1]	1,783	[1]
Total Assets	6,057		3,844
Current Liabilities
Accounts payable and accrued liabilities	84,585		44,128
Loan payable	30,000	[2]	0	[2]
Due to related parties	206,532	[3]	162,941	[3]
Convertible debenture, net of unamortized	189,473	[4]	99,814	[4]
Derivative liabilities, current portion	151,717	[5]	559,382	[5]
TOTAL CURRENT LIABILITIES	662,307		866,265
Derivative liabilities	18,388	[5]	161,142	[5]
TOTAL LIABILITIES	680,695		1,027,407
Stockholders' Deficit
Common Stock	1,086,148	[6]	1,086,148	[6]
Common Stock issuable	225,000	[7]	225,000	[7]
Additional paid-in capital	174,586	[3]	167,086	[3]
Accumulated deficit during the development stage	(2,160,372)		(2,501,797)
Total Stockholders' Deficit	(674,638)		(1,023,563)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 6,057		$ 3,844

[1] See Note 3

[2] See Note 4

[3] See Note 10

[4] net of unamortized discount of $nil and $95,759, respectively. See Note 5

[5] See Note 6

[6] 200,000,000 shares authorized, without par value 35,767,073 shares issued and outstanding.

[7] See Note 7